The new Access to Medicine Index.

摘要

The Access to Medicine Foundation's new index set out to improve access to medicines through a transparent, quantifiable comparison of corporate social responsibility for 20 pharmaceutical companies. It has turned out as an attractive new businesstool for big pharma.The index has taken a strictly business approach to measuring access to essential medicines, presenting data collected from the giant pharmaceutical companies while overlooking crucial information from end-users and local consumers (patients) in developing countries.